Tag archive for ‘pharmaceutical’
Jewish Business News On Sunday, April 23rd, 2017

SteadyMed raises $30 million for Trevyent commercial launch

Drug delivery company SteadyMed Ltd. has raised $30 million in a private placement led by Adage Capital Management, OrbiMed, Deerfield Management and Kingdon Capital Management. SteadyMed’s leading drug More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Niva Goldberg On Thursday, October 22nd, 2015

Perrigo Taking Actions To Fend off Mylan, Deliver Shareholder Value Far Superior To Mylan Offer

Perrigo, which is the target of a hostile takeover bid by Mylan, said Thursday that it would reduce its workforce by approximately 800 employees, or approximately 6 percent of its current global More...

OPKO
Ilan Shavit On Wednesday, May 6th, 2015

Phillip Frost’s OPKO Health Acquires EirGen Pharma for $135 million in cash and shares

  Opko Health (NYSE: OPK; TASE: OPK), controlled by chairman Dr. Phillip Frost,  has acquired EirGen Pharma, Ltd., a pharmaceutical company based in Ireland,  focused on the development and More...

Yossi Nissan On Wednesday, April 22nd, 2015

Perrigo rejects Mylan’s $29 billion takeover bid

  The board of directors of Perrigo Company (NYSE:PRGO; TASE:PRGO) has unanimously rejected the offer by Mylan NV to buy all its shares for $29 billion. Two weeks after receiving the offer, the pharmaceutical More...

Jewish Business News On Tuesday, February 17th, 2015

Biotech Investor Alex Rabinovich Increases Stake in Israel’s XTL Biopharmaceuticals

XTL Biopharmaceuticals Ltd., an Israeli clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical More...

Joseph E. Stiglitz
Professor Joseph Stiglitz On Tuesday, February 10th, 2015

Nobel laureate in economics, Joseph Stiglitz: Obama Versus Obamacare

   The US Patient Protection and Affordable Care Act, President Barack Obama’s signature 2010 health-care reform, has succeeded in extending insurance coverage to millions of Americans who would not More...

Galmed Enters Manufacturing Agreement with Perrigo for Aramchol

Israel’s Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral medication for the treatment of liver diseases and More...

Idan Ofer

ZIM to Launch a New Monitoring and Tracking Service for Sensitive Cargo

Israel’s ZIM integrated shipping services announced the launching of a new monitoring, tracking and security services package, specifically designed for valuable and sensitive cargo stowed in reefer containers. More...

Globes On Monday, January 12th, 2015

Perrigo good acquisition candidate for Teva – report

Bloomberg reports that increased competition with cheaper generics may push Teva to make a major acquisition soon. Perrigo Company (NYSE:PRGO; TASE:PRGO) may be a suitable acquisition for Teva Pharmaceutical More...

Gali Weinreb On Wednesday, December 17th, 2014

BioLineRX signs Novartis strategic cooperation deal

– Novartis will invest $10 million in BioLineRX for a 12.8% stake. They will select three projects for joint development. –   Drug development company BiolineRX Ltd. (Nasdaq: BLRX); TASE:BLRX) More...

Wordpress site Developed by Fixing WordPress Problems